Skip to main content
Erschienen in: Indian Journal of Pediatrics 10/2018

09.05.2018 | Scientific Letter

Novel Gene Mutation in a Chinese Boy with Severe Congenital Neutropenia

verfasst von: Tingting Zou, Jianjun Deng, Min Shu, Qin Guo, Ruixue Miao, Chao-min Wan, Gang Ning, Yu Zhu

Erschienen in: Indian Journal of Pediatrics | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor: Severe congenital neutropenia (SCN) is a heterogeneous group of bone marrow failure syndromes caused by different gene mutations [1]. We encountered a 2 y and 9-mo-old boy presenting with 2 wk of fever. He had a past history of recurrent infection every 1–2 mo after 1 y of age, including recurrent upper respiratory infection, mycotic stomatitis, a perianal abscess, and pneumonia. His development was normal and without any congenital malformation suggestive of specific syndromes. His parents and elder sister were all healthy. The parents were not consanguineous. A physical examination revealed pale skin, cervical lymphadenopathy, weakened breathing sounds in the left lung and hepatosplenomegaly. A laboratory examination revealed severe neutropenia [Absolute neutrophil count (ANC) 0.2 × 109/L], mild anemia, increased humoral immunity and normal cellular immunity. Autoantibodies were all negative. A tuberculin skin test was positive. A CT scan revealed a consolidation shadow in the left lower lobe, hilar and mediastinal lymphadenopathy and left pleural effusion (Fig. 1a). Bone marrow aspiration showed maturation arrest at the promyelocyte/myelocyte stage and markedly decreased mature neutrophils. The anti-tubercular treatment was initiated since the administration of broad-spectrum antibiotic was ineffective. The patient’s temperature eventually recovered to a normal level after 25 d of anti-tubercular treatment and the pulmonary lesions returned to normal eventually (Fig. 1b). During treatment, the ANC was always less than 0.5 × 109/L. SCN was suspected and a genetic analysis was undertaken. The exons of ELANE, GFI1, HAX1, G6PC3, WAS, SBDS and their respected flanking regions were amplified by PCR and sequenced by first generation sequencing. A heterozygous mutation located in exon 3 of ELANE (c.290A > C) was found (Fig. 2), which has never been reported in NCBI (dbSNP). Several previous studies have reported series of mutations in ELANE caused by autosomal dominant or sporadic forms [25]. In this patient, we considered the novel variant as putative pathogenic mutation because the clinical characteristic was typical. Since the parents were both healthy, the mutation was more likely caused by sporadic form. However, a deletion of 40 bases in intron 3 of GFI1 (c.298 + 28_68del40) was also found and we could not identify if it can interact with the previous mutation. Developing a functional test to identify the pathogenic mechanisms of novel gene mutation is the aim of our future work on this disease.
Literatur
1.
Zurück zum Zitat Box LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer. 2007;49:609–14.CrossRef Box LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer. 2007;49:609–14.CrossRef
2.
Zurück zum Zitat Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96:2317–22.PubMed Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96:2317–22.PubMed
3.
Zurück zum Zitat Ishikawa N, Okada S, Miki M, et al. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J Med Genet. 2008;45:802–7.CrossRef Ishikawa N, Okada S, Miki M, et al. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J Med Genet. 2008;45:802–7.CrossRef
4.
Zurück zum Zitat Smith BN, Ancliff BJ, Pizzey A, et al. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. Br J Haematol. 2009;144:762–70.CrossRef Smith BN, Ancliff BJ, Pizzey A, et al. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. Br J Haematol. 2009;144:762–70.CrossRef
5.
Zurück zum Zitat Germeshausen M, Deerberg S, Peter Y, Reimer C, Kratz CP, Ballmaier M. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia. Hum Mutat. 2013;34:905–14.CrossRef Germeshausen M, Deerberg S, Peter Y, Reimer C, Kratz CP, Ballmaier M. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia. Hum Mutat. 2013;34:905–14.CrossRef
Metadaten
Titel
Novel Gene Mutation in a Chinese Boy with Severe Congenital Neutropenia
verfasst von
Tingting Zou
Jianjun Deng
Min Shu
Qin Guo
Ruixue Miao
Chao-min Wan
Gang Ning
Yu Zhu
Publikationsdatum
09.05.2018
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 10/2018
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-018-2685-1

Weitere Artikel der Ausgabe 10/2018

Indian Journal of Pediatrics 10/2018 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.